Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Published Scientific Evidence

Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.

February
16
2026
{post_date: F d, Y}
European Heart Journal

Artificial intelligence 12-lead electrocardiography to determine atrial fibrillation risk among UK Biobank participants with predisposing conditions

Abstract Background Artificial intelligence electrocardiography (AI-ECG) algorithms are emerging tools for identifying individuals at risk of atrial fibrillation (AF). We evaluated the predictive performance of a validated AI-ECG algorithm for…
January
16
2026
{post_date: F d, Y}
JACC

Multisite, External Validation of an AI-Enabled ECG Algorithm for Detection of Low Ejection Fraction

Abstract Background: Low left ventricular ejection fraction (LEF) can progress undiagnosed. Artificial intelligence–based electrocardiogram (ECG-AI) screening may provide a scalable means to detect LEF.Objectives: The purpose of this study was…